Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2873-2878

  Huang, Chuanshu ^a   Ma, Wei Ya ^a   Hecht, Stephen S ^b   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INOSITOL PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTIC ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTICARCINOGENIC AGENTS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; MICE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PHYTIC ACID; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 0030793370     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Theibert, A. B., Estevez, V. A., Mourey, R. J., Marecek, J. F., Barrow, R. K., Prestwich, G. D., and Snyder, S. H. Photoaffimity labeling and characterization of isolated inositol 1,3,4,5-tetrakisphosphate- and inositol hexakisphosphate-binding proteins. J. Biol. Chem., 267: 9071-9079, 1992.
2. Cosgrove, D. J. Inositol phosphates. Their chemistry, biochemistry and physiology. Amsterdam: Elsevier Science Publishers, B.V., 1980.
3. Bunce, C. M., French, P. J., Allen, P., Mountford, J. C., Moor, B., Greaves, M. F., Michell, R. H., and Brown, G. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem. J., 289: 667-673, 1993.
4. 31P NMR. Biochem. Biophys. Res. Commun., 149: 874-881, 1987.
5. Graf, E., and Eaton, J. W. Antioxidant functions of phytic acid. Free Radical Biol. Med., 8: 61-69, 1990.
6. Vallejo, M., Jackson, T. R., Lightman, S., and Hanley, M. R. Occurrence and extracellular actions of inositol penlakis- and hexakisphosphate in mammalian brain. Nature (Lond.), 330: 656-658, 1987.
7. Regunathan, S., Reis, D. J., and Wahlestedt, C. Specific binding of inositol hexakisphosphate (phytic acid) to adrenal chromaffin cell membrane and effects on calcium-dependent catecholamine release. Biochem. Pharmacol., 43: 1331-1336, 1992.
8. 3H] aspartate release in cultured cerebellar neurons. J. Neurochem., 53: 1026-1030, 1989.
9. Voglmaier, S. M., Keen, J. H., Murphy, J. E., Ferris, C. D., Prestwich, G. D., Snyder, S. H., and Theibert, A. B. Inositol hexakisphosphate receptor identified as the clathrin assembly protein AP-2. Biochem. Biophys. Res. Commun., 187: 158-163, 1992.
10. Theibert, A. B., Estevez, V. A., Ferris, C. D., Danoff, S. K., Barrow, R. K., Prestwich, G. D., and Snyder, S. H. Inositol 1,3,4,5-tetrakisphosphate and inositol hexakisphosphate receptor proteins: isolation and characterization from rat brain. Proc. Natl. Acad. Sci. USA, 88: 3165-3169, 1991.
11. Chadwick, C. C., Timerman, A. P., Saito, A., Mayreitner, M., Shindler, H., and Fleischer, S. Structural and functional characterization of an inositol polyphosphate receptor from cerebellum. J. Biol. Chem., 267: 3473-3481, 1992.
12. Cecconi, O., Nelson, R. M., Roberts, W. G., Hanasaki, K., Minnori, G., Scultz, C., Ulrich, T. R., Aruffo, A., and Bevilacqua, M. P. Inositol polyanions. Non-carbohydrate inhibitors of L-and P-selectin that block inflammation. J. Biol. Chem., 269: 15061-15066, 1994.
13. Graf, E., and Empson, K. L. Phytic acid, a natural antioxidant. J. Biol. Chem., 262: 11647-11650, 1987.
14. Vallejo, M., Jackson, T., Lightman, S., and Hanley, M. R. Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature (Lond.), 330: 656-658, 1987.
15. Shamsuddin, A. M., and Yang, G-Y. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis (Lond.), 16: 1975-1979, 1995.
16. Shamsuddin, A. M. Reduction of cell proliferation and enhancement of NK-Cell activity. United States Patent no. 5,082,833, 1992.
17. Shamsuddin, A. M., Elsayed, A. M., and Ullah, A. Suppression of large intestinal cancer in F-344 rats by inositol hexaphosphate. Carcinogenesis (Lond.), 9: 577-580, 1988.
18. Shamsuddin, A. M., Baten, A., and Lalwani, N. D. Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line. Cancer Lett., 64: 195-202, 1992.
19. Sakamoto, K., Venkatraman, G., and Shamsuddin, A. M. Growth inhibition and differentiation of HT-29 cell in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis (Lond.), 14: 1815-1819, 1993.
20. Vucenik, I., Sakamoto, K., Bansal, M., and Shamsuddin, A. M. Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett., 75: 95-102, 1993.
21. Shamsuddin, A. M. and Sakamoto, K. Antineoplastic action of inositol compounds. In: L. W. Wattenberg, M. Lipkin, and G. J. Kelloff (eds.), Cancer Prevention, pp. 285-308. Boca Raton, FL: CRC Press, Inc., 1992.
22. Babich, H., Borenfreund, L., and Stern, A. Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventative properties. Cancer Lett., 73: 127-133, 1993.
23. Hirose, M., Ozaki, K., Takaba, K., Fukushima, S., Shirai, T., and Ito, M. Modifying effects of the naturally occurring antioxidants γ-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis (Lond.), 12: 1917-1921, 1991.
24. Pretlow, T. O., O'Riordan, M. A., and Pretlow, T. G. Colon carcinogenesis is inhibited more effectively by phytate than by selenium in F344 rats given 30 mg/kg azoxymethane. In: M. M. Jacobs (ed.), Diet and Cancer Markers, Prevention and Treatment, p. 244. New York: Plenum Press, 1994.
25. Estensen, R. D., and Wattenberg, L. W. Studies of chemopreventive effects of myo-inositol on benzo(a)pyrene-induced neoplasia of the lung and fore stomach of female A/J mice. Carcinogenesis (Lond.), 14: 1975-1977, 1993.
26. Arnold, J. T., Wilkinson, B. P., Sharma, S., and Steele, V. E. Evaluation of chemo-preventative agents in different mechanistic classes using a rat tracheal epithelial cell culture transformation assay. Cancer Res., 55: 537-543, 1995.
27. Vucenik. I., Yang, G., and Shamsuddin, A. M. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis (Lond.), 16: 1055-1058.
28. Vucenik, I., Tomazic, V. J., Favbian, D., and Shamsuddin, A. M. Antitumor activity of phytic acid in murine transplanted and metastatic fibrosarcoma. Cancer Lett., 65: 9-13, 1992.
29. Powis, G., Berggren, M., Gallegos, A., Frew, T., Hill, S., Kozikowski, A., Bonjouklian, R., Zalkow, L., Abraham, R., Ashendel, C., Shultz, R., and Merriman, R. Advances with phospholipid signalling as a target for anticancer drug development. Acta Biochim. Pol., 42: 395-404, 1995.
30. + cells. Mol. Cell. Biol., 16: 6427-6435, 1996.
31. Huang, H., Schmid, P. C., Ma, W-Y., Schmid, H. H. O., and Dong, Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and AP-1 activation. J. Biol. Chem., 272: 4187-4194, 1997.
32. Kaplan, D. R., Whitman, M., Shaffhausen, B., Pallas, D. C., White, M., Cantley, L., and Roberts, T. M. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell, 50: 1021-1029, 1987.
33. Serunian, L. A., Auger, K. R., Roberts, T., and Cantley, L. C. Production of novel polyphosphoinositides in vivo is linked to cell transformation by polyomavirus middle T antigen. J. Virol., 64: 4718-4725, 1989.
34. Coughlin, S. R., Escobedo, J. A., and Williams, L. T. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science (Washington DC), 243: 1191-1194, 1989.
35. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking tumor promoter induced AP-1 activity inhibits induced transformation in JB6 cells. Proc. Natl. Acad. Sci. USA, 91: 609-613, 1994.
36. Dong, Z., Cmarik, J., Wendel, E. D., and Colburn, N. H. Comparison of AP-1 induction and transformation efficiency in anchorage dependent and independent conditions. Carcinogenesis (Lond.), 15: 1001-1004, 1994.
37. Dong, Z., Watts, R. G., Sun, Y., and Colburn, N. H. Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Int. J. Oncol., 7: 359-364, 1995.
38. Colburn, N. H., Former, B. F., Nelson, K. A., and Yuspa, S. H. Tumor promoter induces anchorage independence irreversibly. Nature (Lond.), 281: 589-591, 1979.
39. Bernstein, L. R., and Colburn, N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science (Washington DC), 244: 566-569, 1989.
40. Li, J-J, Dong, Z., Dawson, M. I., and Colburn, N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res., 56: 483-489, 1996.
41. Huang, C., Ma, W., and Dong, Z. Inhibitory effects of ascorbic acid on AP-1 activity and transformation of JB6 cells. Int. J. Oncol., 8: 389-393, 1996.
42. Huang, C., Ma, W-Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. Blocking activator protein-1 activity, but not activating retinoic acid response clement, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 5826-5830, 1997.
43. Weinstein, I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment: Twenty-seventh G. H. A. Clowes Memorial Award lecture. Cancer Res., 48: 4135-4143, 1988.
44. Matrisian, L. M., McDonnell, S., Miller, D. B., Navre, M., Seftor, H. A., and Hendrix, M. J. C. The role of the matrix methalloproteinase stromelysin in the progression of squamous cell carcinomas. Am. J. Med. Sci., 302: 157-162, 1991.
45. Alani, R., Brown, P., Binetruy, B., Dosaker, H., Rosenberg, R. K., Angel, P., Karin, M., and Birrer, M. J. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol., 11: 6286-6295, 1991.
46. Domann, F. E., Levy, J. P., Birrer, M. J., and Bowden, G. T. Stable expression of a c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth & Differ., 5: 9-16, 1994.
47. Watts, R. G., Ben-Ari, H. T., Bernstein, L. R., Birrer, M. J., Winterstein, D., Wendel, E., and Colburn, N. H. c-Jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensime to tumor promoter-induced transformation. Mol. Carcinog., 13: 27-36, 1995.
48. 6 receptors. Br. J. Pharmacol., 117: 979-985, 1996.
49. Cantley, L. C., Auager, K. R., Carpeter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. Oncogenes and signal transduction (Published erratum in Cell, 65 (Suppl. 5): 1991). Cell, 64: 281-302, 1991.
50. Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., Schaffhausen, B. S., and Cantley, L. C. Purification and characterization of phosphoinositide 3-kinase from rat user. J. Biol. Chem., 265: 19704-19711, 1990.
51. Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., and Cantley, L., C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell, 57: 167-175, 1989.
52. Whitman, M., Downes, C. P., Keller, M., Keller, T., and Cantley, L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature (Lond.), 332: 644-646, 1988.